{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:44:42Z","timestamp":1787510682633,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:00:00Z","timestamp":1537574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Chief Scientist\u2019s Office of the Ministry of Health, Israel","award":["3-10470"],"award-info":[{"award-number":["3-10470"]}]},{"DOI":"10.13039\/501100003977","name":"The Israeli Science Foundation","doi-asserted-by":"crossref","award":["617\/14"],"award-info":[{"award-number":["617\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11695-018-3517-0","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T14:55:09Z","timestamp":1537628109000},"page":"268-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans"],"prefix":"10.1007","volume":"29","author":[{"given":"Shahar","family":"Azar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-7551","authenticated-orcid":false,"given":"Shiri","family":"Sherf-Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Nemirovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnat","family":"Raziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Keidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goitein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Sakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Shibolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Zelber-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,22]]},"reference":[{"issue":"1","key":"3517_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMe1706095","volume":"377","author":"EW Gregg","year":"2017","unstructured":"Gregg EW, Shaw JE. Global health effects of overweight and obesity. N Engl J Med. 2017;377(1):80\u20131.","journal-title":"N Engl J Med"},{"issue":"3","key":"3517_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254\u201366.","journal-title":"N Engl J Med"},{"issue":"9","key":"3517_CR3","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s11695-017-2666-x","volume":"27","author":"L Angrisani","year":"2017","unstructured":"Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279\u201389.","journal-title":"Obes Surg"},{"issue":"5","key":"3517_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MOG.0000000000000383","volume":"33","author":"V Kumbhari","year":"2017","unstructured":"Kumbhari V, Hill C, Sullivan S. Bariatric endoscopy: state-of-the-art. Curr Opin Gastroenterol. 2017;33(5):358\u201365.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"3517_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","volume":"17","author":"C Silvestri","year":"2013","unstructured":"Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475\u201390.","journal-title":"Cell Metab"},{"issue":"1","key":"3517_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43(1):155\u201372.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"3517_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","volume":"26","author":"W Mazier","year":"2015","unstructured":"Mazier W, Saucisse N, Gatta-Cherifi B, et al. The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease. Trends Endocrinol Metab. 2015;26(10):524\u201337.","journal-title":"Trends Endocrinol Metab"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2018.01.009","volume":"49","author":"J Tam","year":"2018","unstructured":"Tam J, Hinden L, Drori A, et al. The therapeutic potential of targeting the peripheral endocannabinoid\/CB1 receptor system. Eur J Intern Med. 2018;49:23\u20139.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"3517_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M Bensaid","year":"2003","unstructured":"Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol Pharmacol. 2003;63(4):908\u201314.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"3517_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/db09-1482","volume":"59","author":"T Jourdan","year":"2010","unstructured":"Jourdan T, Djaouti L, Demizieux L, et al. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice. Diabetes. 2010;59(4):926\u201334.","journal-title":"Diabetes"},{"issue":"9","key":"3517_CR11","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman D, Liu J, Zhou L, et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest. 2008;118(9):3160\u20139.","journal-title":"J Clin Invest"},{"issue":"4","key":"3517_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2010.02.015","volume":"11","author":"C Quarta","year":"2010","unstructured":"Quarta C, Bellocchio L, Mancini G, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab. 2010;11(4):273\u201385.","journal-title":"Cell Metab"},{"issue":"12","key":"3517_CR13","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1681\/ASN.2016101085","volume":"28","author":"S Udi","year":"2017","unstructured":"Udi S, Hinden L, Earley B, et al. Proximal tubular cannabinoid-1 receptor regulates obesity-induced CKD. J Am Soc Nephrol. 2017;28(12):3518\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3517_CR14","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M Bluher","year":"2006","unstructured":"Bluher M, Engeli S, Kloting N, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes. 2006;55(11):3053\u201360.","journal-title":"Diabetes"},{"issue":"10","key":"3517_CR15","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Feldpausch M, et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54(10):2838\u201343.","journal-title":"Diabetes"},{"issue":"4","key":"3517_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","volume":"31","author":"M Cote","year":"2007","unstructured":"Cote M, Matias I, Lemieux I, et al. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes. 2007;31(4):692\u20139.","journal-title":"Int J Obes"},{"issue":"1","key":"3517_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/oby.20498","volume":"22","author":"J Abdulnour","year":"2014","unstructured":"Abdulnour J, Yasari S, Rabasa-Lhoret R, et al. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. Obesity (Silver Spring). 2014;22(1):211\u20136.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"3517_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/oby.21687","volume":"25","author":"S Zelber-Sagi","year":"2017","unstructured":"Zelber-Sagi S, Azar S, Nemirovski A, et al. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. Obesity (Silver Spring). 2017;25(1):94\u2013101.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"3517_CR19","doi-asserted-by":"publisher","first-page":"e8792","DOI":"10.1371\/journal.pone.0008792","volume":"5","author":"JC Sipe","year":"2010","unstructured":"Sipe JC, Scott TM, Murray S, et al. Biomarkers of endocannabinoid system activation in severe obesity. PLoS One. 2010;5(1):e8792.","journal-title":"PLoS One"},{"issue":"5","key":"3517_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/SLA.0b013e318166fd5f","volume":"247","author":"A Guijarro","year":"2008","unstructured":"Guijarro A, Osei-Hyiaman D, Harvey-White J, et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg. 2008;247(5):779\u201390.","journal-title":"Ann Surg"},{"key":"3517_CR21","first-page":"2015","volume":"680867","author":"A Mallipedhi","year":"2015","unstructured":"Mallipedhi A, Prior SL, Dunseath G, et al. Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis. J Diabetes Res. 2015;680867:2015.","journal-title":"J Diabetes Res"},{"issue":"2","key":"3517_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ijo.2017.210","volume":"42","author":"S Sherf-Dagan","year":"2018","unstructured":"Sherf-Dagan S, Zelber-Sagi S, Zilberman-Schapira G, et al. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. Int J Obes. 2018;42(2):147\u201355.","journal-title":"Int J Obes"},{"key":"3517_CR23","first-page":"1968","volume-title":"Editor textbook of gastrointestinal radiology","author":"R Gore","year":"1994","unstructured":"Gore R. Diffuse liver disease. In: Gore R, Levine M, Laufer I, editors. Editor textbook of gastrointestinal radiology. Philadelphia: Saunders; 1994. p. 1968\u20132017."},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2840-11-16","volume":"11","author":"AE Mirrakhimov","year":"2012","unstructured":"Mirrakhimov AE, Lunegova OS, Kerimkulova AS, et al. Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region). Cardiovasc Diabetol. 2012;11:16.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3517_CR25","doi-asserted-by":"publisher","first-page":"e30325","DOI":"10.1371\/journal.pone.0030325","volume":"7","author":"T Poynard","year":"2012","unstructured":"Poynard T, Lassailly G, Diaz E, et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One. 2012;7(3):e30325.","journal-title":"PLoS One"},{"issue":"5","key":"3517_CR26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MEG.0000000000001064","volume":"30","author":"T Poynard","year":"2018","unstructured":"Poynard T, Munteanu M, Charlotte F, et al. Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. Eur J Gastroenterol Hepatol. 2018;30(5):569\u201377.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"3517_CR27","doi-asserted-by":"publisher","first-page":"e42399","DOI":"10.1371\/journal.pone.0042399","volume":"7","author":"I Matias","year":"2012","unstructured":"Matias I, Gatta-Cherifi B, Tabarin A, et al. Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS One. 2012;7(7):e42399.","journal-title":"PLoS One"},{"issue":"6","key":"3517_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","volume":"139","author":"J Westerbacka","year":"2010","unstructured":"Westerbacka J, Kotronen A, Fielding BA, et al. Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology. 2010;139(6):1961\u201371. e1","journal-title":"Gastroenterology"},{"issue":"27","key":"3517_CR29","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/eurheartj\/eht085","volume":"34","author":"A Quercioli","year":"2013","unstructured":"Quercioli A, Montecucco F, Pataky Z, et al. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J. 2013;34(27):2063\u201373.","journal-title":"Eur Heart J"},{"issue":"4","key":"3517_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1160\/TH14-06-0506","volume":"113","author":"F Montecucco","year":"2015","unstructured":"Montecucco F, Lenglet S, Quercioli A, et al. Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. Thromb Haemost. 2015;113(4):838\u201350.","journal-title":"Thromb Haemost"},{"issue":"2","key":"3517_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","volume":"52","author":"V Marzo Di","year":"2009","unstructured":"Di Marzo V, Cote M, Matias I, et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia. 2009;52(2):213\u20137.","journal-title":"Diabetologia"},{"key":"3517_CR32","doi-asserted-by":"publisher","first-page":"256145","DOI":"10.1155\/2013\/256145","volume":"2013","author":"C Johnson Stoklossa","year":"2013","unstructured":"Johnson Stoklossa C, Atwal S. Nutrition care for patients with weight regain after bariatric surgery. Gastroenterol Res Pract. 2013;2013:256145.","journal-title":"Gastroenterol Res Pract"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-018-3517-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-018-3517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-018-3517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T19:16:54Z","timestamp":1569093414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-018-3517-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s11695-018-3517-0","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,22]]},"assertion":[{"value":"22 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in this study were approved by the institutional research committees in both participating hospitals and in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was preregistered in the NIH registration website (TRIAL no. NCT01922830).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Informed Consent"}}]}}